Title : Therapeutic targeting of pancreatic cancer stem cells by dexamethasone modulation of the MKP-1-JNK axis.

Pub. Date : 2020 Dec 25

PMID : 33115754






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Therapeutic targeting of pancreatic cancer stem cells by dexamethasone modulation of the MKP-1-JNK axis. Dexamethasone mitogen-activated protein kinase 8 Homo sapiens
2 Using in vitro models of CSCs and in vivo models of tumor initiation in which CSCs give rise to xenograft tumors, we show that dexamethasone induces expression of MKP-1, a MAPK phosphatase, via glucocorticoid receptor activation, thereby inactivating JNK, which is required for self-renewal and tumor-initiation by pancreatic CSCs as well as for their expression of survivin, an anti-apoptotic protein implicated in multi-drug resistance. Dexamethasone mitogen-activated protein kinase 8 Homo sapiens